Devaux’s and Yuki’s groups described antibodies against nodal proteins in patients with CIDP and Guillain-Barré Syndrome (GBS), including IgG and IgM antibodies against neurofascin, gliomedin, CNTN-1 and NrCAM13. This evidence concerns the gene CD40LG and chronic inflammatory demyelinating polyradiculoneuropathy.